Über Juvisé Pharmaceuticals
Juvisé Pharmaceuticals is a family-owned pharmaceutical company whose mission is to prioritize essential medicines and improve the health of millions of people around the world: approximately 2.5 million patients are treated with our medicines each year.
Since our creation in 2008, our portfolio has been built up through the acquisition of princeps drugs from leading pharmaceutical companies. Today, it includes 10 medications and covers 4 main therapeutic areas: neuroscience, gastroenterology, oncology and cardiology.
Juvisé Pharmaceuticals is an international company with a strong European focus. The majority of our medicines are manufactured in Europe (87% in 2024, with an ambitious target of close to 100% by the end of 2025), and marketed in nearly 80 countries worldwide.
Weitere Informationen zum Unternehmen finden Sie unter www.juvisepharmaceuticals.com.